Skip to main content
. 2022 Jul 25;13:964179. doi: 10.3389/fimmu.2022.964179

Figure 1.

Figure 1

Receiver operating characteristics analysis of healthy control subjects versus COVID-19 patients, using specific biomarkers (A) CRP, C-reactive protein. (B) SAA, serum amyloid A (C) IL-6, interleukin 6. (D) IL-8, interleukin 8. (E) IP-10, interferon-γ-inducible protein-10. (F) TNF-α, tumor necrosis- α. (G) IL-10, interleukin-10. (H) VEGF-D, vascular endothelial growth factor-D. (I) MDC, macrophage-derived chemokine (MDC). (J) VCAM-1, vascular cell adhesion protein 1.